THE GUARDIAN^™ CONNECT SYSTEM

Guardian Connect Continuous Glucose Monitor

THE GUARDIAN^™ CONNECT SYSTEM.

A continuous glucose monitor (CGM) for people living with diabetes that allows you to see glucose levels, trends and alerts on your mobile device.

Are you living with diabetes and on oral medications or multiple daily insulin injections? Are you looking for ways to better manage diabetes?

Watch Video Get started

Now available for both iOS and Android^™ Devices.

To check compatibility for your mobile device click here.

WHAT IS CGM?

Continuous glucose monitoring (CGM) systems track glucose levels, every few minutes, 24/7 through a tiny sensor inserted under your skin, either on your belly or arm using an automatic inserter. The sensor measures your interstitial glucose level, which is the glucose found in the fluid between the cell. CGM therapy can be used with or without an insulin pump.

WHAT IS SMART CGM?

Smart CGM predicts future high and low sensor glucose events up to an hour in advance and provides access to information that can inform you of clinically relevant glucose patterns.^†

See how it works Get started

ACCURATE

Measures sensor glucose 24/7 and sends alerts when a high or low is detected. Without predictive alerts turned on, it has a 90.5% hypoglycemia detection rate (when worn on the abdomen). With predictive alerts turned on and set at 30 minutes before a low, the Guardian^™ Connect system had a 98.5% hypoglycemic detection rate (when worn on the abdomen. With this information, you can take action to help avoid highs and lows.^2,3

Smart CGM

DISCREET

Discreetly view your glucose reading on your smart phone. Get notifications on your mobile device and smart watch.

INFORMATIVE

Trend arrows provide insight on the speed and direction your glucose is heading, customizable predictive alerts help you take action sooner.

REAL-TIME INFORMATION FOR ON THE SPOT DECISIONS

You decide in advance when you want to be alerted between 10-60 minutes in 5 minute increments. Minimum two calibrations per day required.

Guardian Connect Real-time Prediction

Get started

Guardian Connect Sugar.IQ Diabetes Assistant App

Exclusively available with the Guardian^™ Connect system is the
Sugar.IQ^™ Diabetes Assistant app.

Only available for iOS Devices.

The Sugar.IQ^™ assistant supercharges the Guardian^™ Connect system’s smarts by giving you a big picture view of your glucose patterns – and the factors that affect them.

Learn More Get started

Click above to experience the app

TAKE THE NEXT STEP today!
FILL OUT THE FORM BELOW TO GET STARTED.

We will get started on determining your insurance or pharmacy coverage. A member of our team will reach out to you for additional information. If you have questions please contact us at 888-882-8602 (M-F 9 AM-6 PM CDT).

I have read and understand the terms of this marketing authorization. I hereby knowingly and voluntarily authorize Medtronic to use such information for the purposes described in the authorization.

AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION

You authorize Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes or its subsidiaries, contractors or representatives to use your personal information, including but not limited to your contact information and health information, for marketing purposes and to share that information with Medtronic representatives and contractors. Information you may receive includes, but is not limited to: (a) Medtronic Diabetes products, therapies or services; (b) marketing and promotional offers; (c) inquiries about your experience with Medtronic Diabetes products, therapies and services; and/or (d) suggestions for how Medtronic Diabetes can enhance its customer support.

This authorization will expire three (3) years from the later of the date you submit this authorization online; or (ii) the last date products or services were received from Medtronic, but may expire sooner if you revoke it by following the instructions below.

You have the right to revoke this authorization at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating my communication preferences at www.diabetes.shop/myhome. A revocation will not affect actions Medtronic Diabetes has already taken based on this authorization. Information disclosed pursuant to this authorization may be re-disclosed by the recipient of the information and may no longer be protected by the federal privacy standards.

You have the right to refuse to sign this authorization. Refusal to sign will not affect your treatment or health insurance eligibility or benefits.

Questions? Contact our Customer Service Center at 800-646-4633, or by email at takecontrol@medtronic.com.

I have read and understand the terms of this phone communications. I consent to receive phone calls and/or artificial or prerecorded voice messages at the phone number(s) provided above sent from or on behalf of Medtronic Diabetes using automated technology.

CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS

You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

I have read and understand the terms of this text communications. I consent to receive text communications at the mobile phone number provided above using automated technology sent from or on behalf of Medtronic Diabetes (message frequency may vary).

CONSENT FOR RECEIPT OF TEXT COMMUNICATIONS

You consent to receiving text messages at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) texting "STOP" in return to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

FREQUENTLY ASKED QUESTIONS

What is the Guardian^™ Connect Smart^† CGM system?

The Guardian^™ Connect continuous glucose monitoring (CGM) system is the standalone CGM system from Medtronic designed from the ground up to help serve the needs of customers on multiple daily insulin injections. Leveraging both modern mobile technology and the latest advances from Medtronic, the Guardian^™ Connect system provides a smarter^† way to manage your diabetes.

Guardian^™ Connect system individuals can:

See current glucose levels and trends, right on their mobile device, at any time
Get alerts – including predictive alerts up to 60 minutes in advance – of high and low glucose events*
Connect with care partners and healthcare professionals (HCPs) via the CareLink^™ system platform, to enable care partner remote monitoring and HCP therapy optimization when connected to the internet via wifi/mobile data
Access the Sugar.IQ^™ diabetes assistant app for iOS users

How is Guardian^™ Connect system different from other CGM systems?

The Guardian^™ Connect system is the only CGM system with customizable predictive alerts that helps you outsmart both highs and lows. Using smart technology to predict where your glucose levels are headed, the system can alert you from 10 to 60 minutes before a high or low.

Exclusively available to patients using the Guardian^™ Connect system, the Sugar.IQ^™ diabetes assistant app (only available on iOS) to continually analyze how glucose levels react to food, exercise and insulin. Together, the Guardian^™ Connect system and the Sugar.IQ^™ app turn hidden patterns into personalized insights that can help patients make smarter diabetes decisions.¹

How does the Guardian^™ Connect system help with glucose control?

The Guardian^™ Connect CGM system allows you to track your sensor glucose trends in real-time on your compatible mobile device. The Guardian^™ Connect app will also alert you up to an hour before a high or low. Without predictive alerts turned on, it has a 90.5% hypoglycemia detection rate (when worn on the abdomen). With predictive alerts, turned on and set at 30 minutes before a low, the Guardian^™ Connect system had a 98.5% hypoglycemic detection rate (when worn on the abdomen. With this information, you can take action to help avoid highs and lows.^2,3

Do I need a prescription for Guardian^™ Connect CGM system?

In the U.S., customers will need a prescription from their physician for the Guardian^™ Connect system. (While anyone can download the Guardian^™ Connect app, it will not function without being paired to a Guardian^™ transmitter.)

Will my insurance cover this CGM?

We work with more than 600 insurers nationwide and can often help with the process and paperwork. Getting started is easy. Simply fill out the interest form and our team will collect insurance and pharmacy coverage information to get you started.

When will the Guardian^™ Connect CGM system be available for pediatric customers?

The Guardian^™ Connect system is currently indicated for use in customers age 14-75.

What smart device models are compatible with the Guardian^™ Connect continuous glucose monitoring (CGM) system?

The Guardian^™ Connect system compatibility information can be found by visiting Guardian^™ Connect FAQs.

You should confirm compatibility with the Guardian^™ Connect system using this link before updating your operating system.

Does the Guardian^™ Connect system integrate with Medtronic insulin pump systems as well?

The transmitter used with the pump system is different and doesn’t have Bluetooth^® connectivity so it isn’t compatible with the Guardian^™ Connect app. The MiniMed^™ 600-series pumps use the Guardian^™ Link 3 transmitter, which uses a different wireless technology to communicate with the pump. The transmitter shell for the Guardian^™ Connect system also has a “GC” etched on the surface opposed to the pump system transmitter shell, which just has a “G.”

VIEW AND SHARE REPORTS IN 3 EASY STEPS.

SEE THE SAME REPORTS AS YOUR HEALTHCARE PROFESSIONAL -AND
COLLABORATE ON YOUR CARE.

Anytime access to glucose levels and auto uploads to the CareLink^™ Personal software when connected to the internet via wifi/mobile data.

Carelink Connect Platform

ACCESS
FOR CARE PARTNERS.

Stay connected to your family and friends with automatic text message alerts when connected to the internet via wifi/mobile data.

WHAT TO EXPECT WITH MEDTRONIC

COVERAGE

We check your insurance and pharmacy benefits for coverage. You choose the one that is best for you.

TECHNICAL SUPPORT

We have your back. Our 24-Hour Technical Support is staffed 24/7.

PERSONALIZED SUPPORT

Our team of dedicated clinicians will help guide you through training and ongoing support, our goal is that you StartRight^™.

1-YEAR WARRANTY

Peace of mind: we’ll replace your device. See conditions.

30-DAY RETURNS

No regrets: if you’re not happy with our product, you can return it within 30-days – no questions asked.

USING MULTIPLE DAILY INJECTIONS?

i-PORT ADVANCE^™ INJECTION PORT

Learn more about how i-Port Advance^™ injection port can reduce injections.

Learn more

User Guide Getting Started Guide FAQs Sugar.IQ^™ Training Resources USER GUIDE FOR APP VERSION 3.2.4 GETTING STARTED GUIDE FOR APP VERSION 3.2.4

1. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.
2. Guardian^™ Connect system SSED, page 19, Table 5. 90.5% Glucose Correct Detection Rate without Predictive Alerts at both 15 and 30 minutes when worn on the abdomen.
3. Guardian^™ Connect system SSED, page 19, Table 5. 98.5% Glucose Correct Detection Rate based on Predictive Alerts at 30 minutes when worn on the abdomen.
† Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance.
‡ Android is a trademark of Google LLC.

Important Safety Information: Guardian^™ Connect CGM System
The Guardian^™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

Important Safety Information: Sugar.IQ^™ App
The Sugar.IQ^™ app (MMT-8100) helps manage diabetes by facilitating the logging and display of meal entries and sensor glucose (SG) data, tracking meal log entries, reporting insights of how meals affect glucose levels, and supporting good choices and trends with motivational messages. The app serves as an additional display for real-time CGM data from the Guardian^™ Connect system through the CareLink^™ Personal software. It is not intended to provide medical advice and should not be relied upon for such purpose. The app is not intended to replace the real-time display of the CGM data on the Guardian^™ Connect app, control any functions of the connecting device, calculate insulin or other drug doses, or modify date or control functions of the Guardian^™ Connect system. All therapy decisions should be made by the app user based on blood glucose (BG) measurements obtained from a BG meter. Changes to treatment should only be made in consultation with a healthcare professional (HCP). For complete details, consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.

Important Safety Information: CareLink^™ Software
The CareLink^™ software is intended for use as a tool to help manage diabetes. The purpose of the software is to take information transmitted from insulin pumps, glucose meters and continuous glucose monitoring systems, and turn it into CareLink^™ reports. The reports provide information that can be used to identify trends and track daily activities—such as carbohydrates consumed, meal times, insulin delivery, and glucose readings. NOTE: CareLink^™ report data is intended for use as an adjunct in the management of diabetes only and NOT intended to be relied upon by itself. Patients should consult their healthcare providers familiar with the management of diabetes prior to making changes in treatment. For more details, please consult important safety information. and the appropriate CareLink^™ User Guide at http://www.medtronicdiabetes.com/support/download-library/user-guides.

Important Safety Information: i-Port Advance^™ Injection Port
i-Port Advance™ injection port is indicated for patients who administer or receive multiple daily subcutaneous injections of physician prescribed medications, including insulin. The device may remain in place for up to 72 hours to accommodate multiple injections without the discomfort of additional needle sticks. i-Port Advance™ injection port may be used on a wide range of patients, including adults and children. Prescription required. For more, please see http://www.medtronicdiabetes.com/important-safety-information.

© Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.